04.03.2013 14:50 Uhr, Quelle: Wallstreet online

Sixth Merck Serono Spin-off Company to Focus on Gastrointestinal Immunological Disorders

GENEVA, March 4, 2013 /PRNewswire/ - Newly formed Calypso Biotech will continue research and development of preclinical antibody programs from Merck Serono Merck Serono, a division of Merck, Darmstadt, Germany, announced today the creation …

Weiterlesen bei Wallstreet online